Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis
Open accessThe DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
Macrophages specialize in removing lipids and debris present in the atherosclerotic plaque. However, plaque progression renders macrophages unable to degrade exogenous atherogenic material and endogenous cargo including dysfunctional proteins and organelles. Here we show that a decline in the autophagy–lysosome system contributes to this as evidenced by a derangement in key autophagy markers in both mouse and human atherosclerotic plaques. By augmenting macrophage TFEB, the master transcriptional regulator of autophagy–lysosomal biogenesis, we can reverse the autophagy dysfunction of plaques, enhance aggrephagy of p62-enriched protein aggregates and blunt macrophage apoptosis and pro-inflammatory IL-1β levels, leading to reduced atherosclerosis. In order to harness this degradative response therapeutically, we also describe a natural sugar called trehalose as an inducer of macrophage autophagy–lysosomal biogenesis and show trehalose’s ability to recapitulate the atheroprotective properties of macrophage TFEB overexpression. Our data support this practical method of enhancing the degradative capacity of macrophages as a therapy for atherosclerotic vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Atherosclerosis | Macrophage‐specific overexpression of Tfeb | Reduced development of atherogenic plaque after stimulation of lysosomal biogenesis in macrophages | Sergin et al (2017) |”
From Autophagy in major human diseases (2021) · cites this paper as Sergin et al (2017)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Martinez, J., Almendinger, J., Oberst, A., Ness, R., Dillon, C. P., Fitzgerald, P., Hengartner, M. O., & Green, D. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113421108 · Cited by 655
RetractedA SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069 · cited 2×
“In addition, dual TFEB-TG/ ATG5-KO macrophages subjected to atherogenic lipids were no longer able to (1) reduce the number of p62-enriched protein aggregates or (2) blunt the degree of apoptosis (Fig.”
BackgroundGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330
Self-citationNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
TFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365
Self-citationA Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543
Self-citationNew insights on trehalose: a multifunctional molecule
Elbein, A. D. (2003) · Glycobiology · doi:10.1093/glycob/cwg047 · Cited by 1,954
Cited by
Items 101–200 of 364
atherosclerosis: gone with the Wnt?
Boucher, P., Matz, R. L., & Terrand, J. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.03.024 · Cited by 56
Choi, S., Agatisa-Boyle, C., Gonen, A., Kim, A., Kim, J., Alekseeva, E. A., Tsimikas, S., & Miller, Y. I. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315485 · Cited by 54
He, X., Chen, S., Li, C. R., Ban, J., Wei, Y., He, Y., Liu, F., Chen, Y., & Chen, J. (2020) · Cells · doi:10.3390/cells9010122 · Cited by 50
“Consistent with our hypothesis, studies in atherosclerosis and liver fibrosis have indicated that increased TFEB expression abrogates macrophage apoptosis and decreases proinflammatory cytokine levels, which reduces atherosclerosis plaque formation or fibrogenesis [20,24,52].”
BackgroundLiu, S., Yang, Y., Gao, H., Zhou, N., Wang, P., Zhang, Y., Zhang, A., Jia, Z., & Huang, S. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00568.2019 · Cited by 49
Zhang, H., Chen, Y., Li, F., Wu, C., Cai, W., Ye, H., Su, H., He, M., Yang, L., Wang, X., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02690-4 · Cited by 57
“inhibited by CQ To further confirm that the beneficial effects of SS-31 on SCI recovery are due to an increase in autophagic activities, CQ, a classic autophagic flux inhibitor that inhibits lysosomal acidification [51], was used in subsequent”
MethodTFEB signaling attenuates NLRP3‐driven inflammatory responses in severe asthma
Theofani, E., Semitekolou, M., Samitas, Κ., Mais, A., Galani, I. E., Triantafyllia, V., Lama, J., Morianos, I., Stavropoulos, A., Jeong, S., et al. (2022) · Allergy · doi:10.1111/all.15221 · Cited by 47
Self-citationThe Induction of Endothelial Autophagy and Its Role in the Development of Atherosclerosis
Hua, Y., Zhang, J., Liu, Q., Su, J., Zhao, Y., Zheng, G., Yang, Z., Zhuo, D., Ma, C., & Fan, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831847 · Cited by 49
“Trehalose has been shown to promote lysosomal autophagy by activating TFEB nuclear translocation (6), and in another clinical study, oral administration of trehalose reversed arterial aging in middle-aged and elderly people (NCT01575288).”
BackgroundZhang, D., Ma, Y., Liu, J., Deng, Y., Zhou, B., Wen, Y., Li, M., Wen, D.-Y., Ying, Y., Luo, S., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.689111 · Cited by 48
“Furthermore, activating TFEB by ezetimibe and tetrahalose can inhibit the NRLP3-dependent IL-1β production and reduce NAFLD lesions (Kim et al., 2017; Sergin et al., 2017).”
BackgroundTao, J., Yang, P., Xie, L.-Q., Pu, Y., Guo, J., Jiao, J., Sun, L., & Lü, D. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16600 · Cited by 46
Fucoidan reduces lipid accumulation by promoting foam cell autophagy via TFEB
Zhao, J., Hu, B., Han, X., Yang, Q., Cao, Q., Li, X., Zhang, Q., Ji, A., & Song, S. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118247 · Cited by 45
Han, X., Tang, Y., Zhang, Y., Zhang, J., Hu, Z., Xu, W., Xu, S., & Niu, Q. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113500 · Cited by 46
Zhou, Z., Zhu, X., Yin, R., Liu, T., Yang, S., Zhou, L., Pan, X., & Ma, A. (2020) · Aging · doi:10.18632/aging.102710 · Cited by 47
“Autophagy moderates atherosclerosis by engulfing misfolded proteins bounded by p62 [31].”
BackgroundAutophagy: A Friend or Foe in Allergic Asthma?
Theofani, E., & Xanthou, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126314 · Cited by 50
“Increased p62 accumulation, indicative of deficient autophagic flux, is also observed in human atherosclerotic plaques and participates in disease progression [36].”
BackgroundCholesterol crystals in the pathogenesis of atherosclerosis
Baumer, Y., Irei, J. S., & Boisvert, W. A. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01100-3 · Cited by 55
“The inhibition of autophagy is associated with increased CC formation 189,190 .”
Pi, H., Wang, Z., Liu, M., Deng, P., Yu, Z., Zhou, Z., & Gao, F. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14401 · Cited by 42
Wang, Y., Li, X., Chen, J., McConnell, B. K., Chen, L., Li, P., Chen, Y., & Zhang, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1931-4 · Cited by 41
Yoshizane, C., Mizote, A., Arai, C., Arai, N., Ogawa, R., Endo, S., Mitsuzumi, H., & Ushio, S. (2020) · Nutrition Journal · doi:10.1186/s12937-020-00586-0 · Cited by 39
Limanaqi, F., Busceti, C. L., Biagioni, F., Lazzeri, G., Forte, M., Schiavon, S., Sciarretta, S., Frati, G., & Fornai, F. (2020) · Antioxidants · doi:10.3390/antiox9111105 · Cited by 41
Trehalose administration attenuates atherosclerosis in rabbits fed a high‐fat diet
Sahebkar, A., Hatamipour, M., & Tabatabaei, S. A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28221 · Cited by 35
“The current results corroborate those of a primer study in which intraperitoneal trehalose administration was shown to reverse atherosclerosis and enhance macrophage autophagy in APOE‐null mice on a high‐fat diet.(16) Likewise, intraperitoneal trehalose administration was reported to mitigate myocardial infarction‐ind…”
BackgroundResultHoribe, A., Eid, N. A. S., Ito, Y., Otsuki, Y., & Kondo, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010184 · Cited by 39
“The LC3 intensity in SCs were identified using the threshold feature of Image menu of the ImageJ program as reported by us [32] and others [33,34].”
MethodLiu, Q., Wang, Y., & Gu, H. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.10.025 · Cited by 39
B-1b Cells Possess Unique bHLH-Driven P62-Dependent Self-Renewal and Atheroprotection
Pattarabanjird, T., Marshall, M., Upadhye, A., Srikakulapu, P., Garmey, J. C., Haider, A., Taylor, A. M., Lutgens, E., & McNamara, C. A. (2022) · Circulation Research · doi:10.1161/circresaha.121.320436 · Cited by 37
Traughber, C. A., Timinski, K., Prince, A., Bhandari, N., Neupane, K., Khan, M. R., Opoku, E., Opoku, E., Brubaker, G., Shin, J., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033881 · Cited by 41
Zhang, Y., Shaikh, N., Ferey, J. L. A., Wankhade, U. D., Chintapalli, S. V., Higgins, C. B., Crowley, J. R., Heitmeier, M. R., Stothard, A. I., Mihi, B., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.11.295 · Cited by 36
Self-citationLv, G., Wang, B., Li, L., Li, Y., Li, X., He, H., & Kuang, L. (2022) · Bone and Joint Research · doi:10.1302/2046-3758.119.bjr-2021-0443.r2 · Cited by 35
p38 MAPK‐dependent phosphorylation of TFEB promotes monocyte‐to‐macrophage differentiation
Martina, J. A., Jeong, E., & Puertollano, R. (2022) · EMBO Reports · doi:10.15252/embr.202255472 · Cited by 34
“In addition, TFEB overexpression enhances the degradative capacity of activated macrophages to reduce atherosclerosis (Sergin et al , 2017) and stimulates the suppression of tumor-promoting signaling pathways in tumor-associated macrophages (Li et al , 2020).”
Najibi, M., Honwad, H. H., Moreau, J. A., Becker, S. M., & Irazoqui, J. E. (2021) · Autophagy · doi:10.1080/15548627.2021.1911548 · Cited by 35
Geng, Y., Lou, J., Wu, J., Tao, Z., Yang, N., Kuang, J., Wu, Y., Zhang, J., Xiang, L., Shi, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202405759 · Cited by 46
Li, Y., Cho, H., Wang, F., Canela‐Xandri, O., Luo, C., Rawlik, K., Archacki, S. R., Xu, C., Tenesa, A., Chen, Q., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014146 · Cited by 33
Zhang, G., Liu, Z., Deng, J., Liu, L., Li, Y., Weng, S., Guo, C., Zhou, Z., Zhang, L., Wang, X., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03795-9 · Cited by 43
“The lysosomal biogenesis process was also enriched in C2, suggesting its non-negligible potential to benefit from macrophage autophagy-lysosome system-based therapy [41, 42].”
BackgroundNatural Monoterpenes as Potential Therapeutic Agents against Atherosclerosis
Yang, J., Zhong, C., & Yu, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032429 · Cited by 38
Apoptotic β-cells induce macrophage reprogramming under diabetic conditions
Ward, M., Li, G., & Hao, M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004565 · Cited by 35
“Finally, when cells were treated with trehalose, a disaccharide that induces lysosome biogenesis (36), or the antioxidant N-acetylcysteine (NAC), IL-1 secretion was significantly reduced (Fig.”
BackgroundMyeloid folliculin balances mTOR activation to maintain innate immunity homeostasis
Li, J., Wada, S., Weaver, L. K., Biswas, C., Behrens, E. M., & Arany, Z. P. (2019) · JCI Insight · doi:10.1172/jci.insight.126939 · Cited by 31
TFEB: A Emerging Regulator in Lipid Homeostasis for Atherosclerosis
Li, M., Wang, Z., Wang, P., Li, H., & Yang, L. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.639920 · Cited by 38
“…numerous genes of lipid and fatty acid catabolic process, fatty acid-binding, and transport, fatty acid oxidation, sphingolipid catabolic process, steroid catabolic process et al., such the expression of lipid metabolic process genes are perturbed by TFEB overexpression (Settembre et al., 2013).”
BackgroundTargeted theranostic photoactivation on atherosclerosis
Song, J. W., Ahn, J. W., Lee, M. W., Kim, H. J., Kang, D. O., Kim, R. H., Kang, U. G., Kim, Y. H., Han, J., Park, Y. H., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01084-z · Cited by 33
“In the present study, using the common markers of autophagic activity (LC3) and autophagy chaperone (p62) [39], photoactivation with DS-Ce6 was shown to induce autophagic activity in murine atheroma.”
BackgroundNLRP3 Inflammasome in Atherosclerosis: Putting Out the Fire of Inflammation
Shao, B., Xu, H., Zhao, Y.-C., Zheng, X.-R., Wang, F., & Zhao, G.-R. (2022) · Inflammation · doi:10.1007/s10753-022-01725-x · Cited by 34
“Macrophages enter the vascular wall and secrete a large number of inflammatory cytokines, such as tumor necrosis factor (TNF) and interleukin (IL) [48], which further cause the recruitment and aggregation of macrophages and the destruction of vascular wall structure [49].”
BackgroundFu, X., Liu, Y., Zhang, H., Yu, X., Wang, X., Wu, C., & Yang, J. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113598 · Cited by 31
Li, X., Zhou, Y., Zhang, X., Cao, X., Wu, C., & Guo, P. (2017) · Oncotarget · doi:10.18632/oncotarget.21886 · Cited by 33
“Recent studies have demonstrated that macrophage autophagy plays a key role in preventing atherosclerosis [5, 8].”
BackgroundInfluentialSelf-citationAge-Related Impairments in Immune Cell Efferocytosis and Autophagy Hinder Atherosclerosis Regression
Boucher, D. M., Robichaud, S., Lorant, V., Salazar‐León, J., Suliman, I., Rasheed, A., Susser, L. I., Emerton, C., Geoffrion, M., Jong, E. D., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321662 · Cited by 41
Trivedi, P. C., Bartlett, J. J., Mercer, A., Slade, L., Surette, M. E., Ballabio, A., Flibotte, S., Hussein, B., Rodrigues, B. B., Kienesberger, P. C., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165832 · Cited by 34
Self-citationAn Interplay Between Autophagy and Immunometabolism for Host Defense Against Mycobacterial Infection
Paik, S., & Jo, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603951 · Cited by 32
Forte, M., Marchitti, S., Cotugno, M., Nonno, F. D., Stanzione, R., Bianchi, F., Schirone, L., Schiavon, S., Vecchio, D., Sarto, G., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105875 · Cited by 32
TFEB-dependent induction of thermogenesis by the hepatocyte SLC2A inhibitor trehalose
Zhang, Y., Higgins, C. B., Mayer, A. L., Mysorekar, I. U., Razani, B., Graham, M. J., Hruz, P. W., & DeBosch, B. J. (2018) · Autophagy · doi:10.1080/15548627.2018.1493044 · Cited by 30
“despite the beneficial neural, vascular, and hepatic effects of oral trehalose treatment, the previously-reported low peripheral bioavailability [20,27] of trehalose suggested that trehalose may render at least part of its metabolic effects from within the enterohepatic circulation.”
BackgroundSelf-citationMitophagy modulation for the treatment of cardiovascular diseases
Forte, M., D’Ambrosio, L., Schiattarella, G. G., Salerno, N., Perrone, M. A., Loffredo, F. S., Bertero, E., Pilichou, K., Manno, G., Valenti, V., et al. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14199 · Cited by 32
“86 Inhibition of autophagy in fat-fed low-density lipoprotein (LDL) receptor (Ldlr) knockout mice ( Ldlr −/−), exacerbates oxidative stress and promotes plaque necrosis in advanced atherosclerosis.”
BackgroundAggregation is impaired in starved platelets due to enhanced autophagy and cellular energy depletion
Paul, M., Hemshekhar, M., Kemparaju, K., & Girish, K. S. (2018) · Platelets · doi:10.1080/09537104.2018.1475630 · Cited by 30
“autophagy inducer in macrophages they demonstrate the increased clearance of exogenous atherogenic material by macrophages rendering protection against atherosclerosis (45).”
BackgroundLuteolin Induces Apoptosis and Autophagy in Mouse Macrophage ANA-1 Cells via the Bcl-2 Pathway
Liao, Y., Yang, X., Cao, M., Huan, Y., Zhu, L., Jiang, Y., Shen, W., & Zhu, G. (2018) · Journal of Immunology Research · doi:10.1155/2018/4623919 · Cited by 32
Zhao, Y. F., Hong, Z., Lin, Y., Shen, W., Yang, Y., Zuo, Z., & Hu, X. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114380 · Cited by 31
Cobo, I., Murillo‐Saich, J., Alishala, M., Calderon, S., Coras, R., Hemming, B., Inkum, F., Rosas, F., Takei, R., Spann, N. J., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.023 · Cited by 34
Self-citationDanielson, N. D., Collins, J., Stothard, A. I., Dong, Q. Q., Kalera, K., Woodruff, P. J., DeBosch, B. J., Britton, R. A., & Swarts, B. M. (2019) · Chemical Communications · doi:10.1039/c9cc01300h · Cited by 30
Hu, B., Xu, L., Li, Y., Bai, X., Xing, M., Cao, Q., Liang, H., Song, S., & Ji, A. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112723 · Cited by 29
Carnevale, R., Nocella, C., Schiavon, S., Cammisotto, V., Cotugno, M., Forte, M., Valenti, V., Marchitti, S., Vecchio, D., Biondi‐Zoccai, G., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15399 · Cited by 28
Chen, W.-L., Xiao, W., Liu, X., Yuan, P., Zhang, S., Wang, Y., & Wu, W. T. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.09.027 · Cited by 37
The Function, Regulation and Mechanism of Programmed Cell Death of Macrophages in Atherosclerosis
Liu, C., Jiang, Z., Pan, Z., & Yang, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809516 · Cited by 33
“Moreover, macrophages can create broad-spectrum cytokines and chemokines that cause atherosclerosis to influence plaque stability, and inflammatory responses of macrophages are also a driving force for atherosclerotic progression and plaque growth (Shashkin et al., 2005; Shimada, 2009).”
BackgroundExercise Ameliorates Atherosclerosis via Up-Regulating Serum β-Hydroxybutyrate Levels
Xu, Z., Zhang, M., Li, X., Wang, Y., & Du, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073788 · Cited by 31
Trehalose-Bearing Carriers to Target Impaired Autophagy and Protein Aggregation Diseases
Maruf, A., Milewska, M., Varga, M., & Wandzik, I. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01442 · Cited by 30
Mani, K. M., Javaheri, A., & Diwan, A. (2018) · Comprehensive physiology · doi:10.1002/cphy.c180005 · Cited by 31
Self-citationWang, Y., Chen, J., Li, X., Umetani, M., Chen, Y., Li, P., & Zhang, Y. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00294.2019 · Cited by 26
Beyond Self-Recycling: Cell-Specific Role of Autophagy in Atherosclerosis
Henderson, J. M., Weber, C., & Santovito, D. (2021) · Cells · doi:10.3390/cells10030625 · Cited by 30
Besler, K. J., Blanchard, V., & Francis, G. A. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1013266 · Cited by 28
“, 2014), and to reduce atherosclerosis in a mouse model (Sergin et al., 2017); whether the significantly lower LIPA expression in SMCs could be similarly enhanced requires further investigation.”
BackgroundNovel Beneficial Cardiovascular Effects of Natural Activators of Autophagy
Frati, G., Vecchione, C., & Sciarretta, S. (2018) · Circulation Research · doi:10.1161/circresaha.118.313530 · Cited by 27
“Autophagy also attenuates vascular damage and lessens atherosclerosis development.(2,3)”
BackgroundXu, X., Wang, R., Wu, R., Yan, W., Shi, T., Jiang, Q. Y., & Shi, D. (2020) · The FASEB Journal · doi:10.1096/fj.201902528rrr · Cited by 26
Vascular Metabolism as Driver of Atherosclerosis: Linking Endothelial Metabolism to Inflammation
Dzobo, K. E., Hanford, K., & Kroon, J. (2021) · Immunometabolism · doi:10.20900/immunometab20210020 · Cited by 29
Liu, C., Chen, G., Chen, Y., Dang, Y., Nie, G., Wu, D., Li, J., Chen, Z., Yang, H., He, D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.724670 · Cited by 25
Lipid Droplets as Regulators of Metabolism and Immunity
Boucher, D. M., Vijithakumar, V., & Ouimet, M. I. (2021) · Immunometabolism · doi:10.20900/immunometab20210021 · Cited by 28
Yuan, H., Zheng, C., Zhu, L., Song, Z., Dai, L., Hu, Q., Wang, L., Chen, Y., & Xiong, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110949 · Cited by 26
Busnelli, M., Manzini, S., Chiara, M., Colombo, A., Fontana, F., Oleari, R., Potì, F., Horner, D. S., Bellosta, S., & Chiesa, G. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315669 · Cited by 24
Zhou, K., Chen, H. A., Xu, H., & Jia, X. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8898996 · Cited by 25
Wang, L., Zhang, X., Zhang, H., Wang, X., Ren, X., Bian, W., Shi, C., Wang, J., Li, L., Zhang, R., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c08671 · Cited by 23
Self-citationNew insights into foam cells in atherosclerosis
Ai, J., Tang, X., Zhou, Y., Mao, B., Zhang, Q., Zhao, J., Chen, W., & Cui, S. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf202 · Cited by 26
Current Status of Autophagy Enhancers in Metabolic Disorders and Other Diseases
Park, K., & Lee, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.811701 · Cited by 26
Microbial and metabolic impacts of trehalose and trehalose analogues
Zhang, Y., & DeBosch, B. J. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1750273 · Cited by 23
Potential Fast COVID-19 Containment With Trehalose
Martinon, D., Borges, V., Gomez, A. C., & Shimada, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01623 · Cited by 24
Caveolin-1 in autophagy: A potential therapeutic target in atherosclerosis
Hou, K., Li, S., Zhang, M., & Qin, X. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.11.020 · Cited by 25
Liu, L., Zheng, Z., Huang, Y., Su, H., Wu, G., Deng, Z., Li, Y., Xie, G., Li, J., Zou, F., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2421703 · Cited by 24
“…inhibition of HSP90 N-terminal induces MDVs with reduced LC3, and it is known that LC3 is a mitophagy-related target gene regulated by TFEB [18,54,55], we next focused on the regulatory and MVBs (green arrows) in HepG2 cells treated with STA9090 for 24 h. Scale bar: 2 μm and 500 nm. (D) TOMM20…”
Qu, W., Zhou, X., Jiang, X., Xie, X., Xu, K.-J., Gu, X., Na, R., Piao, M., Xi, X., Sun, N., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319037 · Cited by 24
Autophagy as an emerging therapeutic target for age-related vascular pathologies
Munck, D. G. D., Meyer, G. R. Y. D., & Martinet, W. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1723079 · Cited by 20
Formation and Cellular Impact of Cholesterol Crystals in Health and Disease
Baumer, Y., McCurdy, S., & Boisvert, W. A. (2021) · Advanced Biology · doi:10.1002/adbi.202100638 · Cited by 26
Alalawi, S., Albalawi, F., & Ramji, D. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108476 · Cited by 20
“Overall, lysosomal dysfunction is one of the multiple causes of atherosclerosis progression [54].”
BackgroundShen, X., Yang, H., Yang, Y., Zhu, X., & Sun, Q. (2024) · MedComm · doi:10.1002/mco2.664 · Cited by 23
“59,60 However, sustained nutritional over-load causes mTORC1 hyperactivation and impairment of TFEB-mediated ALP, thereby leading to lipid accumulation and MAFLD.”
BackgroundMetabolic Reprogramming of Macrophages in Atherosclerosis: Is It All about Cholesterol?
Yvan‐Charvet, L., & Ivanov, S. (2020) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2020.9.2.231 · Cited by 20
Role of macrophage autophagy in atherosclerosis: modulation by bioactive compounds
Zahid, M. K., Sufian, H. B., Choudhury, M., Yamasaki, M., Al‐Harrasi, A., Moustaïd‐Moussa, N., & Rahman, S. M. (2021) · Biochemical Journal · doi:10.1042/bcj20200894 · Cited by 22
Ke, S., Lai, Y., Li, L., Tu, L., Wang, Y., Ren, L., Ye, S., & Yang, P. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01253 · Cited by 20
Inflammasomes: a preclinical assessment of targeting in atherosclerosis
Stitham, J., Rodríguez-Vélez, A., Zhang, X., Jeong, S., & Razani, B. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1795831 · Cited by 21
Self-citationChen, Y., Yu, F., Zhang, Y., Li, M., Di, M., Chen, W., Liu, X., Zhang, Y., & Zhang, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.673366 · Cited by 20
“The main mechanism is that cholesterol esters are stored in LDs, soluble in lysosomes, and hydrolysed by lysosomal acid lipase (LAL) into free cholesterol, then flows out of the cell (Sergin et al., 2017).”
BackgroundJamialahmadi, T., Emami, F., Bagheri, R. K., Alimi, H., Bioletto, F., Bo, S., Aminzadeh, B., Ansari, M. A., Ehsani, F., Rajabi, O., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112632 · Cited by 23
“Trehalose injection has been demonstrated to increase TFEB levels and nuclear translocation, which are likely to harness macrophage autophagy while decreasing macrophage apoptosis, protein aggregation, and IL-1 production [17,31].”
BackgroundContinuous intake of Trehalose induces white adipose tissue Browning and Enhances energy metabolism
Arai, C., Arai, N., Arai, S., Yoshizane, C., Miyata, S., Mizote, A., Suyama, A., Endo, S., Ariyasu, T., Mitsuzumi, H., et al. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0373-4 · Cited by 21
Wang, C., Yang, W., Liang, X., Song, W., Lin, J., Sun, Y., & Guan, X. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03839-y · Cited by 19
Dong, X., He, Y., An, J., He, L., Zheng, Y., Wang, X., Wang, J., Chen, S., & Zhang, Y. (2023) · Autophagy · doi:10.1080/15548627.2023.2234228 · Cited by 22
“Therefore, autophagosome aggregation may be the result of an activation of autophagosome formation or a blockage of late stages in autophagy, similar to fusion blockage or lyso-some dysfunction [31].”
Singh, B., Cui, K., Eisa-Beygi, S., Zhu, B., Cowan, D. B., Shi, J., Wang, D., Liu, Z., Bischoff, J. E., & Chen, H. (2024) · Vascular Pharmacology · doi:10.1016/j.vph.2024.107368 · Cited by 27
Trehalose induces macrophage autophagy–lysosomal biogenesis
Huynh, K. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.97 · Cited by 18
Autophagy: A new target for the treatment of atherosclerosis
Sun, Y., & Guan, X. (2018) · Frontiers in Laboratory Medicine · doi:10.1016/j.flm.2018.07.002 · Cited by 18
Proteomic landscape of human coronary artery atherosclerosis
Zhou, Y., Yuan, J., Fan, Y., An, F., Chen, J., Zhang, Y., Jin, J., Gu, M., Mao, Z., Sun, H., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4600 · Cited by 18
“The results of the present study coincide with those of previous studies where it has been demonstrated that the altered mitochondrial dynamics and mitochondrial dysfunction are also key features of coronary artery disease (20,21), and may shed light on the current understanding of the molecular mechanism of coronary…”
TAK1-AMPK Pathway in Macrophages Regulates Hypothyroid Atherosclerosis
Yang, Y., Jia, Y., Ning, Y., Wen, W., Qin, Y., Zhang, H., Du, Y., Li, L., Jiao, X., Yang, Y., et al. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-06996-w · Cited by 18
Cai, M.-Y., Jiang, X.-S., Wei, Y.-X., Wen, R.-Z., & Du, X. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149472 · Cited by 18
Trehalose enhances bone fracture healing in a rat sleep deprivation model
Xu, X., Wang, R., Sun, Z., Wu, R., Yan, W., Jiang, Q. Y., & Shi, D. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.05.73 · Cited by 19
Yang, G., Li, M., Zheng, X., Chen, X., Yang, P., Li, J., Shui-qing, Y., Chen, H., Wang, Y., Zhang, H., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c01639 · Cited by 20
(13898205), T. J., (18985826), F. E., (18985829), R. B., (18985832), H. A., (18985835), F. B., (13339194), S. B., (18985838), B. A., (16722927), M. A., (18985841), F. E., (18985844), O. R., et al. (2024) · Figshare · Cited by 16
Yu, Q., He, Y., Qiong, A., & Zhang, W. (2023) · International Heart Journal · doi:10.1536/ihj.23-087 · Cited by 17
“14,26) In this study, we also verified that Tan IIA could markedly decrease foam cell formation induced by ox-LDL in RAW264.”
Wang, K., Zhou, W., Hu, G., Wang, L., Cai, R., & Tian, T. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04981-8 · Cited by 19
“In the AS model, the accumulation of atherosclerotic plaque in mice with TFEB conditionally overexpressed in macrophages was less and the content of proinflammatory factor interleukin-1β (IL-1β) in serum was also lower than that in wild type mice [5].”
InfluentialDoonan, L. M., Fisher, E. A. A., & Brodsky, J. L. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.03.010 · Cited by 22
Metadata
- Authors
- Sergin, I., Evans, T. D., Zhang, X., Bhattacharya, S., Stokes, C. J., Song, E., Ali, S., Dehestani, B., Holloway, K. B., Micevych, P. S., Javaheri, A., Crowley, J. R., Ballabio, A., Schilling, J. D., Epelman, S., Weihl, C. C., Diwan, A., Fan, D., Zayed, M. A., & Razani, B.
- Affiliations
- Washington University in St. Louis (US)
- Telethon Institute Of Genetics And Medicine (IT)
- University Health Network (CA)
- University of South Carolina (US)
- Corresponding author
- Razani, Babak
- ORCID
- Venue
- Nature Communications
- Published
- 2017-06-07
- Volume
- 8
- Issue
- 1
- Pages
- 15750-15750
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5467270
- OpenAlex
- W2622769153
- Cited by
- 351
- References
- 52
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 35 · 2023: 35 · 2022: 50 · 2021: 55 · 2020: 50 · 2019: 32 · 2018: 31 · 2017: 5
- FWCI
- 25.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Veterans Affairs (I01BX001969)
- Foundation for Barnes-Jewish Hospital
- National Heart, Lung, and Blood Institute (K08HL132060, R01HL116626, F31HL132434, K08HL098559, R01HL107594, T32HL007081, R01HL125838)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341, P30DK020579)
- National Center for Complementary and Integrative Health (P01AT003961)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- atherosclerosis, macrophages, TFEB, aggrephagy, trehalose, macrophage apoptosis, IL-1β, atherosclerotic plaque, autophagy dysfunction, atherosclerosis treatment
- MeSH terms
- Sequestosome-1 Protein, Animals, Autophagy, Humans, Lysosomes, Macrophages, Mice, Inbred C57BL, Mice, Transgenic, Microtubule-Associated Proteins, Trehalose, Mice, Knockout, Atherosclerosis, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.